- 27 March
-
A meeting of the Committee on Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry was held in Ekaterinburg on March 18, 2025, chaired by Alexander Petrov. Participants of the event, including representatives of the Association of Medical Specialists for Risk Modification, the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, the Ural Biomedical Cluster and members of the Committee considered key challenges in maintaining the health of the able-bodied population, fighting against socially significant diseases and regulating prices for vital drugs.
- 05 December
-
The Russian pharmaceutical industry has gained significant stability in the recent years thanks to manufacturers such as Medsintez Plant. This is a modern full-cycle biotechnological enterprise that develops and manufactures pharmaceutical ingredients and drugs that meet international GMP and ISO standards.
- 27 September
-
On September 26, 2024, TASS hosted an expert discussion in the format of a federal teleconference Moscow-St. Petersburg-Ekaterinburg-Novosibirsk-Vologda-Anapa, dedicated to discussing the role, reasons and mechanisms for stimulating In Ekaterinburg, Alexander Petrov, the Chairman of the Board of Directors of Medsintez Plant LLC, told the participants about Triazavirin, an innovative domestic antiviral drug, as a success case of private investment in science.
- 07 September
-
60 leading Russian reproductologists visited the pharmaceutical company Medsintez Plant in Novouralsk on September 4, 2024. This event was timed to coincide with the celebration of the 3rd anniversary of the opening of the production workshop for biotechnological substances for the reproductive health of women, as well as the Annual International Conference «Reproductive Technologies Today and Tomorrow» in Ekaterinburg. Leading experts and conference speakers visited the production of the first Russian follitropin alpha for the treatment of human infertility, Primapur®.
- Home
- Cluster members
- The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary» is the leading medical center in the region providiry specialized high-tech healthcare assistance for the oncological patients at Sverdlovsk region.
The Sverdlovsk Regional Oncological Dispensary is the participant of the national project «Healthcare», the federal project «Fight against oncological diseases», the largest oncological clinic in the Middle Urals and the head institution of the oncological service of the Sverdlovsk region. All modern methods for the diagnostic and treatment of available on the base of the oncological center.
Every year, medical staff performs over 22 400 surgeries, 29 200 chemotherapy courses and 8 100 radiation therapy courses actually.
The potential of medicine grows. The issues of early diagnosis and treatment of malignant neoplasms are of particular interest. Sverdlovsk oncologists improve their knowledge and skills at all-Russian and international scientific forums, conferences, symposiums. Specialists of oncological dispensary teach general practicants in new methods of treating and diagnosing oncological diseases, and conduct classes for patients and their relatives.
The oncological dispensary aim is to make modern medical oncological care affordable and of high quality. The Sverdlovsk Regional Oncology Center is focused on the highest world standards.
The Sverdlovsk Regional Oncological Dispensary branches in Yekaterinburg, Branch №1 in the city of Nizhny Tagil and Branch №2 in the city of Kamensk-Uralsky.
